Kirkland Steers Deal For Majority Stake In Swixx Biopharma
Healthcare investor HBM said Monday that it has agreed to sell a majority stake in Swixx Biopharma to U.S.-based investor SK Capital Partners LP in a deal that values the Swiss...To view the full article, register now.
Already a subscriber? Click here to view full article